Combined effect of fluoride and arsenate on gene expression of osteoclast differentiation factor and osteoprotegerin

Biomedical and Environmental Sciences

Volumn 19, Issue 5, 2006, Pages 375-379

  Jia, Lin ^a   Jin, Tai Yi ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Arsenate; Combined effect; Fluoride; ODF; OPG

Indexed keywords

ANTICARIES AGENT; ARSENIC ACID; ARSENIC ACID DERIVATIVE; FLUORIDE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; BONE; CYTOLOGY; DANGEROUS GOODS; DRUG EFFECT; GENE EXPRESSION; GENETICS; NEWBORN; OSTEOBLAST; RAT;

ANIMALS; ANIMALS, NEWBORN; ARSENATES; BONE AND BONES; CARIOSTATIC AGENTS; FLUORIDES; GENE EXPRESSION; HAZARDOUS SUBSTANCES; OSTEOBLASTS; OSTEOPROTEGERIN; RANK LIGAND; RATS;

EID: 33845483669     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. National Research Council (1999). Arsenic in the Drinking Water. National Research Council, National Academy of Sciences, Washington, DC: National Academy Press.
2. International Programme on Chemical Safety (2001). Environmental Health Criteria 224: Arsenic and Arsenic Compounds (second edition). Geneva. World Health Organization, 128-129.
3. Huang Y Z, Qian X C, Wang G Q, et al. (1992). Syndrome of endemic arsenism and fluorosis. Chinese Medical Journal 105(7), 586-590.
4. Li D S, Cutress T W, Pearce E I F, et al. (1996). The experimental studies of combined effect of fluoride and arsenic on bone of rats. Chinese J of Control of Endemic Dis 11(3), 134-136.
5. Takahashi N, Yamana H, Yoshiki S, et al. (1988). Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122(4), 1373-1382.
6. Mizuno A, Murakami A, Nakagawa N, et al. (1998). Structure of the mouth osteoclastogenesis inhibitory factor (OCIF) gene and its expression in embryogenesis. Gene 215, 339-343.
7. Lacey D L, Timms E, Tan H L, et al. (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176.
8. Kong Y Y, Yoshida H, Sarosi I, et al. (1999). OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323.
9. Simonet W S, Lacey D L, Dunstan C R, et al. (1997). Osteoprotegerin: a novel secreted protein involved in regulation of bone density. Cell 89, 309-19.
10. Yasuda H, Shima N, Nakagawa N, et al. (1998). Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139(3), 1329-1337.
11. Atkins G J, Haynes D R, Geary S M, et al. (2000). Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation. Bone 26, 653-661.